Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $1.48 billion. The enterprise value is $1.43 billion.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 353.93 million shares outstanding. The number of shares has increased by 16.90% in one year.
| Current Share Class | 353.93M |
| Shares Outstanding | 353.93M |
| Shares Change (YoY) | +16.90% |
| Shares Change (QoQ) | +15.34% |
| Owned by Insiders (%) | 11.89% |
| Owned by Institutions (%) | 34.75% |
| Float | 168.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 147.29 |
| Forward PS | 12.11 |
| PB Ratio | 69.73 |
| P/TBV Ratio | 571.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 147.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.09, with a Debt / Equity ratio of 4.70.
| Current Ratio | 3.09 |
| Quick Ratio | 2.74 |
| Debt / Equity | 4.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.57 |
Financial Efficiency
Return on equity (ROE) is -571.97% and return on invested capital (ROIC) is -69.61%.
| Return on Equity (ROE) | -571.97% |
| Return on Assets (ROA) | -44.30% |
| Return on Invested Capital (ROIC) | -69.61% |
| Return on Capital Employed (ROCE) | -90.19% |
| Weighted Average Cost of Capital (WACC) | 9.96% |
| Revenue Per Employee | $60,525 |
| Profits Per Employee | -$2.69M |
| Employee Count | 160 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Precigen has paid $3,000 in taxes.
| Income Tax | 3,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +260.68% in the last 52 weeks. The beta is 1.12, so Precigen's price volatility has been higher than the market average.
| Beta (5Y) | 1.12 |
| 52-Week Price Change | +260.68% |
| 50-Day Moving Average | 3.97 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 59.64 |
| Average Volume (20 Days) | 5,758,076 |
Short Selling Information
The latest short interest is 39.79 million, so 11.24% of the outstanding shares have been sold short.
| Short Interest | 39.79M |
| Short Previous Month | 41.88M |
| Short % of Shares Out | 11.24% |
| Short % of Float | 23.56% |
| Short Ratio (days to cover) | 8.31 |
Income Statement
In the last 12 months, Precigen had revenue of $9.68 million and -$429.64 million in losses. Loss per share was -$1.37.
| Revenue | 9.68M |
| Gross Profit | -36.47M |
| Operating Income | -106.60M |
| Pretax Income | -250.64M |
| Net Income | -429.64M |
| EBITDA | -103.40M |
| EBIT | -106.60M |
| Loss Per Share | -$1.37 |
Full Income StatementBalance Sheet
The company has $97.86 million in cash and $98.29 million in debt, with a net cash position of -$432,000 or -$0.00 per share.
| Cash & Cash Equivalents | 97.86M |
| Total Debt | 98.29M |
| Net Cash | -432,000 |
| Net Cash Per Share | -$0.00 |
| Equity (Book Value) | 20.91M |
| Book Value Per Share | 0.06 |
| Working Capital | 77.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$87.83 million and capital expenditures -$2.00 million, giving a free cash flow of -$89.83 million.
| Operating Cash Flow | -87.83M |
| Capital Expenditures | -2.00M |
| Depreciation & Amortization | 3.20M |
| Net Borrowing | 92.82M |
| Free Cash Flow | -89.83M |
| FCF Per Share | -$0.25 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,100.78% |
| Pretax Margin | -2,588.18% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.90% |
| Shareholder Yield | -16.90% |
| Earnings Yield | -30.12% |
| FCF Yield | -6.30% |
Analyst Forecast
The average price target for Precigen is $8.33, which is 98.57% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.33 |
| Price Target Difference | 98.57% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 129.23% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -19.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.32 |
| Piotroski F-Score | 3 |
